263 related articles for article (PubMed ID: 23161632)
1. When inhibitors do not inhibit: critical evaluation of rational drug design targeting chorismate mutase from Mycobacterium tuberculosis.
Munack S; Leroux V; Roderer K; Ökvist M; van Eerde A; Gundersen LL; Krengel U; Kast P
Chem Biodivers; 2012 Nov; 9(11):2507-27. PubMed ID: 23161632
[TBL] [Abstract][Full Text] [Related]
2. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
Agrawal H; Kumar A; Bal NC; Siddiqi MI; Arora A
Bioorg Med Chem Lett; 2007 Jun; 17(11):3053-8. PubMed ID: 17418569
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Discovery and structure optimization of a series of isatin derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
Jeankumar VU; Alokam R; Sridevi JP; Suryadevara P; Matikonda SS; Peddi S; Sahithi S; Alvala M; Yogeeswari P; Sriram D
Chem Biol Drug Des; 2014 Apr; 83(4):498-506. PubMed ID: 24636345
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium tuberculosis chorismate mutase: A potential target for TB.
Khanapur M; Alvala M; Prabhakar M; Shiva Kumar K; Edwin RK; Sri Saranya PS; Patel RK; Bulusu G; Misra P; Pal M
Bioorg Med Chem; 2017 Mar; 25(6):1725-1736. PubMed ID: 28202315
[TBL] [Abstract][Full Text] [Related]
6. Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
Alokam R; Jeankumar VU; Sridevi JP; Matikonda SS; Peddi S; Alvala M; Yogeeswari P; Sriram D
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):547-54. PubMed ID: 24090423
[TBL] [Abstract][Full Text] [Related]
7. Novel alkynyl substituted 3,4-dihydropyrimidin-2(1H)-one derivatives as potential inhibitors of chorismate mutase.
Mallikarjuna Rao V; Mahesh Kumar P; Rambabu D; Kapavarapu R; Shobha Rani S; Misra P; Pal M
Bioorg Chem; 2013 Dec; 51():48-53. PubMed ID: 24012092
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.
Wang D; Zhu X; Cui C; Dong M; Jiang H; Li Z; Liu Z; Zhu W; Wang JG
J Chem Inf Model; 2013 Feb; 53(2):343-53. PubMed ID: 23316686
[TBL] [Abstract][Full Text] [Related]
9. 1.6 A crystal structure of the secreted chorismate mutase from Mycobacterium tuberculosis: novel fold topology revealed.
Okvist M; Dey R; Sasso S; Grahn E; Kast P; Krengel U
J Mol Biol; 2006 Apr; 357(5):1483-99. PubMed ID: 16499927
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach.
Schmidt MF; Korb O; Howard NI; Dias MV; Blundell TL; Abell C
ChemMedChem; 2013 Jan; 8(1):54-8. PubMed ID: 23169689
[TBL] [Abstract][Full Text] [Related]
11. Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach.
Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; de Logu A; Manetti F; Botta M
ChemMedChem; 2011 Apr; 6(4):593-9. PubMed ID: 21341373
[TBL] [Abstract][Full Text] [Related]
12. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulations.
Maharaj Y; Soliman ME
Chem Biol Drug Des; 2013 Aug; 82(2):205-15. PubMed ID: 23614896
[TBL] [Abstract][Full Text] [Related]
14. C-N bond formation under Cu-catalysis: synthesis and in vitro evaluation of N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones against chorismate mutase.
Adepu R; Shiva Kumar K; Sandra S; Rambabu D; Rama Krishna G; Malla Reddy C; Kandale A; Misra P; Pal M
Bioorg Med Chem; 2012 Sep; 20(17):5127-38. PubMed ID: 22863527
[TBL] [Abstract][Full Text] [Related]
15. Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
Huang Q; Mao J; Wan B; Wang Y; Brun R; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Nov; 52(21):6757-67. PubMed ID: 19817445
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of aza inhibitors of chorismate mutase.
Hediger ME
Bioorg Med Chem; 2004 Sep; 12(18):4995-5010. PubMed ID: 15336279
[TBL] [Abstract][Full Text] [Related]
17. A review on various heterocyclic moieties and their antitubercular activity.
Sharma S; Sharma PK; Kumar N; Dudhe R
Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
Thomas KD; Adhikari AV; Chowdhury IH; Sandeep T; Mahmood R; Bhattacharya B; Sumesh E
Eur J Med Chem; 2011 Oct; 46(10):4834-45. PubMed ID: 21880400
[TBL] [Abstract][Full Text] [Related]
19. Microbiology. TB--a new target, a new drug.
Cole ST; Alzari PM
Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
[No Abstract] [Full Text] [Related]
20. New tuberculosis drugs on the horizon.
Cole ST; Riccardi G
Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
